Category Archives: "Partners"

CMSC 2017 Annual Meeting – Celgene’s investigational therapy Ozanimod safe, effective in treating RMS
Long-term treatment for up to 12o weeks, with the investigational drug Ozanimod (RPC-1063), found to be effective and safe in patients [...]
CMSC 2017 Annual Meeting – Rituxan-treated multiple sclerosis patients three times more likely to have improved brain scans
Multiple sclerosis patients who start Rituxan (rituximab) treatment are three times more likely to have unchanged or improved brain-scan [...]
CMSC 2017 Annual Meeting – review suggests certain multiple sclerosis patient groups may discontinue DMTs
Older patients with secondary progressive multiple sclerosis (SPMS) as well as older relapsing patients whose MS has been inactive after [...]
CMSC 2017 Annual Meeting – Tysabri improves mental outlook for patients with secondary progressive MS
Long-term therapy with Tysabri (natalizumab) significantly improved the mental state of people with secondary progressive multiple [...]
CMSC 2017 Annual Meeting – multiple sclerosis patients should contribute to outcome measure development, study argues
Patients must help develop new outcome measures of multiple sclerosis (MS), since they and healthcare providers may have differing [...]
CMSC 2017 Annual Meeting – single session of ball-throwing exercise improves balance control in multiple sclerosis
Patients with relapsing-remitting multiple sclerosis (RRMS) regain part of their balance control after a single training session of [...]
CMSC 2017 Annual Meeting – Genentech starts site to connect multiple sclerosis patients and caregivers with resources
Genentech has rolled out a website to connect multiple sclerosis (MS) patients and caregivers with resources that can help [...]
CMSC 2017 Annual Meeting – all about teamwork in multiple sclerosis
NEW ORLEANS — The Consortium of Multiple Sclerosis Centers (CMSC) annual meetings always aim to offer a multidisciplinary educational [...]
The hidden costs of multiple sclerosis
MS is sneaky. It is expert at evading detection and diagnosis, and often brings a host of invisible symptoms that may come and go at [...]
David Sackett trial of the year awarded to the Oratorio Study
At the ongoing Annual Meeting of the Society for Clinical Trials that is being jointly held with the International Clinical Trials [...]

CMSC provides leadership in clinical research and education; develops vehicles to share information and knowledge among members; disseminates information to the health care community and to persons affected by MS.

Contact Us
Contact Us
I have a question about
First
Last

Feel Free To contact Us
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam molestie, tellus id pellen tesque feugiat, sem sem cursus orci, a placerat ante ante nec massa. consectetuer adipiscing elit.

+1-222-333-4444

New York, NY 10123 USA

Mon - Sat 9:00 AM